COM:SPEROTHERAPEUTICS
Spero Therapeutics
- Stock
locale
United Statesmarket
STOCKSindustry
Biopharmaceuticalwebsite
sperotherapeutics.comcrunchbase
spero-therapeuticslinkedin
spero-therapeuticsfounding date
Jan 01, 2013ipo date
Nov 02, 2017
Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product candidates include tebipenem pivoxil hydrobromide (HBr), an oral carbapenem-class antibiotic to treat complicated urinary tract i...Show More